Literature DB >> 11781279

Mucosal flora in inflammatory bowel disease.

Alexander Swidsinski1, Axel Ladhoff, Annelie Pernthaler, Sonja Swidsinski, Vera Loening-Baucke, Marianne Ortner, Jutta Weber, Uwe Hoffmann, Stefan Schreiber, Manfred Dietel, Herbert Lochs.   

Abstract

BACKGROUND & AIMS: Microorganisms that directly interact with the intestinal mucosa are obscured by fecal flora and poorly characterized.
METHODS: We investigated the mucosal flora of washed colonoscopic biopsies of 305 patients with bowel inflammation and 40 controls. The microbial cultures were validated by quantitative polymerase chain reaction with subsequent cloning and sequencing, fluorescence in-situ hybridization, and electron microscopy.
RESULTS: We found high concentrations of mucosal bacteria in patients with bowel inflammation, but not in controls. The concentrations of mucosal bacteria increased progressively with the severity of disease, both in inflamed and non-inflamed colon. In patients with >10,000 cfu/microL, a thick bacterial band was attached to the intact mucosa without signs of translocation. Patients with inflammatory bowel disease (IBD) and concentrations of mucosal bacteria >50,000 cfu/microL had characteristic inclusions of multiple polymorphic bacteria within solitary enterocytes located next to the lamina propria, without or having no contact with the fecal stream. The identified bacteria were of fecal origin.
CONCLUSIONS: Our findings suggest that the changes in the mucosal flora in IBD are not secondary to inflammation, but a result of a specific host response. We hypothesize that the healthy mucosa is capable of holding back fecal bacteria and that this function is profoundly disturbed in patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781279     DOI: 10.1053/gast.2002.30294

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  405 in total

Review 1.  Probiotics and inflammatory bowel disease.

Authors:  Daisy Jonkers; Reinhold Stockbrügger
Journal:  J R Soc Med       Date:  2003-04       Impact factor: 5.344

Review 2.  Potential role of chitinases and chitin-binding proteins in host-microbial interactions during the development of intestinal inflammation.

Authors:  H T Tran; N Barnich; E Mizoguchi
Journal:  Histol Histopathol       Date:  2011-11       Impact factor: 2.303

3.  Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats.

Authors:  Jin-Hyung Lee; Sushil Chandra Regmi; Jung-Ae Kim; Moo Hwan Cho; Hyungdon Yun; Chang-Soo Lee; Jintae Lee
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

4.  Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.

Authors:  Michael Davenport; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Ilseung Cho; P'ng Loke
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

5.  Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.

Authors:  James P Moran; Jens Walter; Gerald W Tannock; Susan L Tonkonogy; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

6.  Adaptation of Akkermansia muciniphila to the Oxic-Anoxic Interface of the Mucus Layer.

Authors:  Janneke P Ouwerkerk; Kees C H van der Ark; Mark Davids; Nico J Claassens; Teresa Robert Finestra; Willem M de Vos; Clara Belzer
Journal:  Appl Environ Microbiol       Date:  2016-09-23       Impact factor: 4.792

7.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

10.  SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice.

Authors:  Reka Szigeti; Stephanie A Pangas; Dorottya Nagy-Szakal; Scot E Dowd; Robert J Shulman; Anthony P Olive; Edwina J Popek; Milton J Finegold; Richard Kellermayer
Journal:  Ann Clin Lab Sci       Date:  2012       Impact factor: 1.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.